Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
imnewrun Biosciences, Inc.
INTERNAL ADDRESS
A-5F, N Center, 2066, Seobu-ro,
*MAILING ADDRESS
Jang-an-gu Suwon-si,
*CITY
Gyeonggi-do,
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Korea, South
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
16419
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Korea, South
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease,
alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations
for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the
treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral
sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Microorganisms for medical purposes;
Biotechnological preparation for medical purposes; Cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Clinical research and development of medicines;
Pharmaceutical products evaluation; Research and development of technology for medicinal chemical manufacturing; scientific study and research in the field of medicine; scientific research in the
nature of evaluating clinical trials; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Protein analysis; Development of biotechnology; Providing
laboratory research services in the field of biology; Research in the field of gene analysis; Research and development in the pharmaceutical and biotechnology fields
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical and health services relating to DNA, genetics and genetic testing; Genetic testing for medical research and treatment purposes;
Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling
for medical purposes; Medical diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes
FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT
Applicant's complete address is: A-5F, N Center, 2066, Seobu-ro, Jang-an-gu Suwon-si, Gyeonggi-do, 16419 Republic of Korea
ATTORNEY INFORMATION
NAME
DENNIS S. PRAHL
ATTORNEY DOCKET NUMBER
1T22756497
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Ladas & Parry LLP
STREET
1040 Avenue of the Americas
CITY
New York
STATE
New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
10018
PHONE
212-708-1817
FAX
212.246.8959
EMAIL ADDRESS
nyustmp@ladas.com
OTHER APPOINTED ATTORNEY
Lanning G. Bryer, Bharati Bakshani, Ralph H. Cathcart, Scott J. Lebson and Sebastian Lovera Riso
CORRESPONDENCE INFORMATION
NAME
DENNIS S. PRAHL
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
nyustmp@ladas.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
dprahl@ladas.com; MThompson@ladas.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
NOT PROVIDED
SIGNATORY'S NAME
NOT PROVIDED
SIGNATORY'S POSITION
NOT PROVIDED
DATE SIGNED
NOT PROVIDED
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97359213
Filing Date:04/12/2022
To the Commissioner for Trademarks:
MARK: iPAM (Standard Characters, see mark)
The literal element of the mark consists of iPAM. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, imnewrun Biosciences, Inc., a corporation of Korea, South, having an address of
A-5F, N Center, 2066, Seobu-ro,
Jang-an-gu Suwon-si,
Gyeonggi-do, 16419
Korea, South
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's
disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion
genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic
disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune
related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Microorganisms for medical purposes; Biotechnological preparation for medical purposes;
Cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Clinical research and development of medicines; Pharmaceutical products
evaluation; Research and development of technology for medicinal chemical manufacturing; scientific study and research in the field of medicine; scientific research in the nature of evaluating
clinical trials; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Protein analysis; Development of biotechnology; Providing laboratory research
services in the field of biology; Research in the field of gene analysis; Research and development in the pharmaceutical and biotechnology fields
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Medical and health services relating to DNA, genetics and genetic testing; Genetic testing for medical research and treatment purposes; Provision of genetic testing for
medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical
diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Miscellaneous Statement
Applicant's complete address is: A-5F, N Center, 2066, Seobu-ro, Jang-an-gu Suwon-si, Gyeonggi-do, 16419 Republic of Korea
The owner's/holder's proposed attorney information: DENNIS S. PRAHL. Other appointed attorneys are Lanning G. Bryer, Bharati Bakshani, Ralph H. Cathcart, Scott J. Lebson and Sebastian Lovera
Riso. DENNIS S. PRAHL of Ladas & Parry LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
1040 Avenue of the Americas
New York, New York 10018
United States
212-708-1817(phone)
212.246.8959(fax)
nyustmp@ladas.com
The docket/reference number is 1T22756497.
DENNIS S. PRAHL submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97359213
Payment Accounting Date: 04/12/2022
Serial Number: 97359213
Internet Transmission Date: Tue Apr 12 15:42:44 ET 2022
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20220412154244938
903-97359213-82080e7b37efee69c526b8a3e4e
1db8ca8bbec07f2a1d1eab13c6dd2b48d94aae1-
DA-42444234-20220412153923711310